← Back
Data updated: Mar 29, 2026
PADAGIS US
DermatologyInfectious DiseaseOphthalmology
Generics
PADAGIS US is a generic drug manufacturer focused on Dermatology, Infectious Disease, Ophthalmology.
1971
Since
68
Drugs
-
Trials
366
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 36%
5 drugs
Infectious Disease 29%
4 drugs
Ophthalmology 14%
2 drugs
Cardiovascular 14%
2 drugs
Neurology 7%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular
AbbVie big-pharma
Neurology, Infectious Disease, Ophthalmology
Active (38)
BRINZOLAMIDE TAVABOROLE LOTEPREDNOL ETABONATE SCOPOLAMINE LEVOCETIRIZINE DIHYDROCHLORIDE TROSPIUM CHLORIDE CLINDAMYCIN PALMITATE HYDROCHLORIDE CETIRIZINE HYDROCHLORIDE CALCIUM ACETATE EVAMIST CLINDESSE PILOCARPINE HYDROCHLORIDE FLAVOXATE HYDROCHLORIDE DIHYDROERGOTAMINE MESYLATE CENTANY PODOFILOX ENTOCORT EC COMPRO CYCLOSPORINE KETOCONAZOLE DESOXIMETASONE CICLOPIROX CLINDETS NYSTOP HYDROMORPHONE HYDROCHLORIDE CLOTRIMAZOLE CLINDA-DERM ALBUTEROL SULFATE CLINDAMYCIN PHOSPHATE IBUPROFEN BETAMETHASONE DIPROPIONATE HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE MIDAMOR TESTOSTERONE CYPIONATE NYSTATIN FLUOCINONIDE ERYTHROMYCIN SULFACETAMIDE SODIUM
Discontinued (30)
EFINACONAZOLE TRETINOIN SUCRALFATE MORPHINE SULFATE POTASSIUM CHLORIDE MOMETASONE FUROATE CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE REPAGLINIDE HYDROCORTISONE HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE LIDOCAINE AND PRILOCAINE MIDAZOLAM HYDROCHLORIDE AZELASTINE HYDROCHLORIDE GENTAMICIN SULFATE TOBRAMYCIN AND DEXAMETHASONE BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE DESONIDE BROMOCRIPTINE MESYLATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC NARATRIPTAN NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE BACITRACIN ZINC AND POLYMYXIN B SULFATE BACITRACIN BUTOCONAZOLE NITRATE STIE-CORT SELENIUM SULFIDE BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE TRIPLE SULFA
Company Info
- First Approval
- 1971-11-09
- Latest
- 2026-02-09
- Applications
- 92